The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era

Detalles Bibliográficos
Autores principales: Kobayashi, T, Kuroda, J, Yokota, I, Tanba, K, Fujino, T, Kuwahara, S, Isa, R, Yamaguchi, J, Kawata, E, Akaogi, T, Uchiyama, H, Kaneko, H, Uoshima, N, Kobayashi, Y, Teramukai, S, Taniwaki, M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group 2016
Materias:
Letter to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742628/
https://www.ncbi.nlm.nih.gov/pubmed/26771809
http://dx.doi.org/10.1038/bcj.2015.111
_version_ 1782414228305477632
author Kobayashi, T
Kuroda, J
Yokota, I
Tanba, K
Fujino, T
Kuwahara, S
Isa, R
Yamaguchi, J
Kawata, E
Akaogi, T
Uchiyama, H
Kaneko, H
Uoshima, N
Kobayashi, Y
Teramukai, S
Taniwaki, M
author_facet Kobayashi, T
Kuroda, J
Yokota, I
Tanba, K
Fujino, T
Kuwahara, S
Isa, R
Yamaguchi, J
Kawata, E
Akaogi, T
Uchiyama, H
Kaneko, H
Uoshima, N
Kobayashi, Y
Teramukai, S
Taniwaki, M
author_sort Kobayashi, T
collection PubMed
description
format Online
Article
Text
id pubmed-4742628
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher Nature Publishing Group
record_format MEDLINE/PubMed
spelling pubmed-47426282016-02-22 The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era Kobayashi, T Kuroda, J Yokota, I Tanba, K Fujino, T Kuwahara, S Isa, R Yamaguchi, J Kawata, E Akaogi, T Uchiyama, H Kaneko, H Uoshima, N Kobayashi, Y Teramukai, S Taniwaki, M Blood Cancer J Letter to the Editor Nature Publishing Group 2016-01 2016-01-15 /pmc/articles/PMC4742628/ /pubmed/26771809 http://dx.doi.org/10.1038/bcj.2015.111 Text en Copyright © 2016 Macmillan Publishers Limited http://creativecommons.org/licenses/by/4.0/ This work is licensed under a Creative Commons Attribution 4.0 International License. The images or other third party material in this article are included in the article's Creative Commons license, unless indicated otherwise in the credit line; if the material is not included under the Creative Commons license, users will need to obtain permission from the license holder to reproduce the material. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/
spellingShingle Letter to the Editor
Kobayashi, T
Kuroda, J
Yokota, I
Tanba, K
Fujino, T
Kuwahara, S
Isa, R
Yamaguchi, J
Kawata, E
Akaogi, T
Uchiyama, H
Kaneko, H
Uoshima, N
Kobayashi, Y
Teramukai, S
Taniwaki, M
The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
title The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
title_full The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
title_fullStr The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
title_full_unstemmed The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
title_short The Kyoto Prognostic Index for patients with diffuse large B-cell lymphoma in the rituximab era
title_sort kyoto prognostic index for patients with diffuse large b-cell lymphoma in the rituximab era
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4742628/
https://www.ncbi.nlm.nih.gov/pubmed/26771809
http://dx.doi.org/10.1038/bcj.2015.111
work_keys_str_mv AT kobayashit thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kurodaj thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT yokotai thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT tanbak thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT fujinot thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kuwaharas thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT isar thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT yamaguchij thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kawatae thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT akaogit thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT uchiyamah thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kanekoh thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT uoshiman thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kobayashiy thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT teramukais thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT taniwakim thekyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kobayashit kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kurodaj kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT yokotai kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT tanbak kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT fujinot kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kuwaharas kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT isar kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT yamaguchij kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kawatae kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT akaogit kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT uchiyamah kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kanekoh kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT uoshiman kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT kobayashiy kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT teramukais kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera
AT taniwakim kyotoprognosticindexforpatientswithdiffuselargebcelllymphomaintherituximabera

Ejemplares similares